Radiation boosts immunotherapy in spreading cancers: early trial opens
NCT ID NCT07269080
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This early-phase study tests whether adding precise radiation to up to 10 tumor spots can improve the effectiveness of immunotherapy in people with advanced solid tumors that have spread to 3-10 places. About 28 adults will receive the combination and be monitored for changes in tumor DNA in their blood. The goal is to see if this approach can better control the disease, though it is not expected to be a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60612, United States
Contact
Conditions
Explore the condition pages connected to this study.